• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.利用靶向配体和细胞穿透肽之间的协同作用增强 siRNA 向细胞内的递送。
Biomaterials. 2011 Sep;32(26):6194-203. doi: 10.1016/j.biomaterials.2011.04.053. Epub 2011 Jun 12.
2
Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.双功能化氧化石墨烯增强 siRNA 递送至乳腺癌细胞。
Colloids Surf B Biointerfaces. 2016 Nov 1;147:315-325. doi: 10.1016/j.colsurfb.2016.08.015. Epub 2016 Aug 12.
3
Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.用细胞穿透肽功能化的液晶纳米分散体用于局部递送短干扰RNA:一种在皮肤病中沉默促炎细胞因子的方案。
J Biomed Nanotechnol. 2016 May;12(5):1063-75. doi: 10.1166/jbn.2016.2211.
4
Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.通过主动靶向系统对肿瘤和脂肪组织血管进行抗血管生成的纳米治疗。
Biomater Sci. 2015 Sep;3(9):1253-65. doi: 10.1039/c5bm00113g.
5
Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.用于体内 siRNA 递送的核壳型脂质/rPAA-Chol 聚合物杂化纳米粒子。
Biomaterials. 2014 Feb;35(6):2066-78. doi: 10.1016/j.biomaterials.2013.11.046. Epub 2013 Dec 7.
6
Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.载有 Angiopep-2 和可激活细胞穿透肽的双修饰纳米粒,用于增强肿瘤靶向和穿透能力。
Int J Pharm. 2014 Oct 20;474(1-2):95-102. doi: 10.1016/j.ijpharm.2014.08.020. Epub 2014 Aug 17.
7
Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer.细胞穿透肽修饰的载雷帕霉素靶蛋白复合物 siRNA 的石墨烯氧化物纳米粒子治疗三阴性乳腺癌。
Drug Des Devel Ther. 2021 Dec 10;15:4961-4972. doi: 10.2147/DDDT.S330059. eCollection 2021.
8
Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.细胞穿透肽偶联脂质纳米粒用于 siRNA 递送。
Biochem Biophys Res Commun. 2014 Feb 21;444(4):599-604. doi: 10.1016/j.bbrc.2014.01.107. Epub 2014 Jan 31.
9
Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.基于穿透细胞的 α-螺旋多肽的亚稳定纳米颗粒实现肿瘤的系统性 siRNA 递药。
Nanoscale. 2018 Aug 16;10(32):15339-15349. doi: 10.1039/c8nr03976c.
10
Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.利用非共价 PEG 化壳聚糖纳米粒递呈靶向肿瘤代谢的 siRNA:鉴定配体结构、连接子和接枝方法的最佳组合。
J Control Release. 2016 Feb 10;223:53-63. doi: 10.1016/j.jconrel.2015.12.020. Epub 2015 Dec 14.

引用本文的文献

1
Biodistribution of Polymeric Nanoparticles following in utero Delivery to a Nonhuman Primate.子宫内给药后聚合物纳米颗粒在非人灵长类动物体内的生物分布
Biomed Hub. 2024 Dec 12;10(1):23-32. doi: 10.1159/000543138. eCollection 2025 Jan-Dec.
2
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy.细胞穿透肽与 CRISPR-Cas9:用于人类遗传疾病治疗的联合策略。
Hum Gene Ther. 2024 Oct;35(19-20):781-797. doi: 10.1089/hum.2024.020.
3
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.线粒体适应性在癌症耐药中的作用:普遍性、机制与管理。
J Hematol Oncol. 2022 Jul 18;15(1):97. doi: 10.1186/s13045-022-01313-4.
4
Surface conjugation of antibodies improves nanoparticle uptake in bronchial epithelial cells.抗体表面缀合可提高支气管上皮细胞对纳米颗粒的摄取。
PLoS One. 2022 Apr 6;17(4):e0266218. doi: 10.1371/journal.pone.0266218. eCollection 2022.
5
MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization.负载微小RNA-539-5p且接枝整合素靶向肽(iRGD)的聚乳酸-羟基乙酸共聚物纳米粒用于脉络膜新生血管的靶向治疗
Pharmaceutics. 2022 Jan 20;14(2):243. doi: 10.3390/pharmaceutics14020243.
6
A Novel Zr-labeled DDS Device Utilizing Human IgG Variant (scFv): "Lactosome" Nanoparticle-Based Theranostics for PET Imaging and Targeted Therapy.一种利用人IgG变体(scFv)的新型锆标记药物递送系统(DDS)装置:基于“乳脂质体”纳米颗粒的正电子发射断层扫描(PET)成像与靶向治疗的诊疗一体化技术
Life (Basel). 2021 Feb 18;11(2):158. doi: 10.3390/life11020158.
7
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs.了解核酸和基因药物的体内命运以进行药物的合理设计。
Pharmaceutics. 2021 Jan 26;13(2):159. doi: 10.3390/pharmaceutics13020159.
8
Multifunctional Delivery Systems for Peptide Nucleic Acids.用于肽核酸的多功能递送系统。
Pharmaceuticals (Basel). 2020 Dec 25;14(1):14. doi: 10.3390/ph14010014.
9
MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.MicroRNA-155 促进 MAPK 信号通路下游丛状神经纤维瘤的生长。
Oncogene. 2021 Feb;40(5):951-963. doi: 10.1038/s41388-020-01581-9. Epub 2020 Dec 8.
10
Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.依库珠单抗治疗脊髓性肌萎缩症
Yonsei Med J. 2020 Apr;61(4):273-283. doi: 10.3349/ymj.2020.61.4.273.

本文引用的文献

1
Generation of stable cell lines expressing GFP-tubulin and photoactivatable-GFP-tubulin and characterization of clones.表达绿色荧光蛋白-微管蛋白和光激活绿色荧光蛋白-微管蛋白的稳定细胞系的生成及克隆鉴定。
Cold Spring Harb Protoc. 2010 Sep 1;2010(9):pdb.prot5480. doi: 10.1101/pdb.prot5480.
2
Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation.载紫杉醇、叶酸靶向和 TAT 肽偶联的聚合物脂质体:体外和体内评价。
Pharm Res. 2010 Sep;27(9):1914-26. doi: 10.1007/s11095-010-0196-5. Epub 2010 Jun 26.
3
Surface functionalisation of PLGA nanoparticles for gene silencing.PLGA 纳米粒的表面功能化用于基因沉默。
Biomaterials. 2010 Jul;31(21):5671-7. doi: 10.1016/j.biomaterials.2010.03.069.
4
Morphing low-affinity ligands into high-avidity nanoparticles by thermally triggered self-assembly of a genetically encoded polymer.通过基因编码聚合物的热触发自组装将低亲和力配体转化为高亲和力纳米颗粒。
ACS Nano. 2010 Apr 27;4(4):2217-27. doi: 10.1021/nn901732h.
5
Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency.配体修饰的基因载体增加了靶细胞的摄取,但降低了 DNA 释放和转染效率。
Nanomedicine. 2010 Apr;6(2):334-43. doi: 10.1016/j.nano.2009.09.001. Epub 2009 Oct 2.
6
Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.叶酸偶联的混合脂质单层壳和可生物降解聚合物核纳米粒子,用于多西紫杉醇的靶向递送。
Biomaterials. 2010 Jan;31(2):330-8. doi: 10.1016/j.biomaterials.2009.09.036. Epub 2009 Sep 26.
7
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.纳米颗粒逃避网状内皮系统:支撑双层膜的作用。
Biochim Biophys Acta. 2009 Oct;1788(10):2259-66. doi: 10.1016/j.bbamem.2009.06.022. Epub 2009 Jul 10.
8
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA.使用负载有小干扰RNA的可生物降解聚合物纳米颗粒进行阴道内基因沉默。
Nat Mater. 2009 Jun;8(6):526-33. doi: 10.1038/nmat2444. Epub 2009 May 3.
9
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.聚乳酸-羟基乙酸共聚物纳米颗粒在上皮细胞中的摄取及细胞内命运
Biomaterials. 2009 May;30(14):2790-8. doi: 10.1016/j.biomaterials.2009.01.057. Epub 2009 Feb 20.
10
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.自组装脂质-聚合物杂化纳米颗粒:一种强大的药物递送平台。
ACS Nano. 2008 Aug;2(8):1696-702. doi: 10.1021/nn800275r.

利用靶向配体和细胞穿透肽之间的协同作用增强 siRNA 向细胞内的递送。

Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.

机构信息

Department of Biomedical Engineering, Yale University, 55 Prospect Street, MEC 414, New Haven, CT 06511, USA.

出版信息

Biomaterials. 2011 Sep;32(26):6194-203. doi: 10.1016/j.biomaterials.2011.04.053. Epub 2011 Jun 12.

DOI:10.1016/j.biomaterials.2011.04.053
PMID:21664689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3130098/
Abstract

We have developed a polymer nanoparticle-based siRNA delivery system that exploits a cell surface binding synergism between targeting ligands and cell-penetrating peptides. Nanoparticles were coated with folate and penetratin via a PEGylated phospholipid linker (DSPE-PEG): the combination of both of these ligands represents a strategy for enhancing intracellular delivery of attached polymer nanoparticles. Nanoparticles were characterized for size, morphology, density of surface modification, and ligand association and retention. The surface coverage achieved on DSPE-PEG-coated nanoparticles is as high as (or higher than) obtained with other ligand-modified nano-scale particulate systems (∼0.5-5 pmol ligand/cm²). Additionally, these nanoparticles were loaded with a high density of siRNA (∼130-140 pmol siRNA/mg nanoparticles), which is slowly released upon incubation in water. Synergies between the activity of surface binding and cell internalizing ligands on these siRNA-loaded nanoparticles impart delivery enhancements that improve their gene silencing efficacy both in culture and in tumor models. Traditionally, targeting ligands function by binding to cell surface receptors, while cell-penetrating peptides function by nonspecifically transporting across cell membranes. Interestingly, we have observed that improved delivery of these dual-functionalized nanoparticles was in part, a result of increased cell surface avidity afforded by both ligands. This siRNA delivery system presents an approach to surface modification of nanovehicles, in which multiple ligands function in parallel to enhance cell binding and uptake.

摘要

我们开发了一种基于聚合物纳米粒子的 siRNA 递药系统,该系统利用靶向配体和穿膜肽之间的细胞表面结合协同作用。通过聚乙二醇化磷脂连接子(DSPE-PEG)将叶酸和穿透肽包覆在纳米粒子上:这两种配体的结合代表了增强附着聚合物纳米粒子细胞内递药的策略。对纳米粒子的大小、形态、表面修饰密度以及配体结合和保留情况进行了表征。DSPE-PEG 包覆纳米粒子的表面覆盖率高达(或高于)其他经配体修饰的纳米级颗粒系统(∼0.5-5 pmol 配体/cm²)。此外,这些纳米粒子负载了高密度的 siRNA(∼130-140 pmol siRNA/mg 纳米粒子),在水中孵育时会缓慢释放。这些负载 siRNA 的纳米粒子表面结合和细胞内化配体的协同作用赋予了递药增强作用,提高了它们在培养物和肿瘤模型中的基因沉默效果。传统上,靶向配体通过与细胞表面受体结合发挥作用,而穿膜肽则通过非特异性跨细胞膜运输发挥作用。有趣的是,我们观察到,这些双功能化纳米粒子的递药增强作用部分是由于两种配体赋予的细胞表面亲和力增加所致。这种 siRNA 递药系统提出了一种纳米载体表面修饰的方法,其中多个配体平行作用以增强细胞结合和摄取。